An Open-label 52-Week Safety Study of Bicifadine SR in Adult Outpatients with Chronic Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
100 Clinical Results associated with XTL Development, Inc.
0 Patents (Medical) associated with XTL Development, Inc.
100 Deals associated with XTL Development, Inc.
100 Translational Medicine associated with XTL Development, Inc.